Curcumin: a 103-RCT meta-analysis shows which parts work — and where it's weak

Human evidence: B- (some outcomes at high certainty, overall mixed) Updated: October 2026

Summary: A large 2024 meta-analysis (103 RCTs, 7,216 participants) found statistically significant effects on 23 of 42 measured outcomes. Fasting glucose, CRP (inflammation), HDL and body weight were the strongest, at high certainty. Dose and formulation variability, and poor absorption, are constant caveats. The classic "hangover" and "liver detox" marketing is not supported by these numbers.

What is claimed (the benefit side)

Anti-inflammatory and antioxidant action, glucose and lipid improvement, joint pain relief, liver protection, memory — curcumin's claim range is unusually wide. Ingredients with wide claims tend to have evidence that varies outcome by outcome.

What has actually been measured

The 103-RCT meta-analysis (Adv Nutr 2024)

Outcome	Result	Certainty
Fasting blood glucose (FBS)	Significantly improved	High
CRP (inflammation marker)	Significantly lowered	High
HDL cholesterol	Significantly raised	High
Body weight	Significantly reduced	High
HOMA-IR, BMI, waist circumference etc.	Significant changes	Moderate
28 of the 42 outcomes	No significant difference, or low/very-low certainty	Low

Joints (osteoarthritis)

A meta-analysis of meta-analyses (umbrella review, 2024) found significant improvements in VAS pain scores and WOMAC (pain, function, stiffness). Trials comparing curcumin against NSAIDs repeatedly report results that "hold their own".

Non-alcoholic fatty liver disease (NAFLD)

A meta-analysis of 21 RCTs found significant improvements in fasting glucose, triglycerides, total and LDL cholesterol, body weight and BMI — with the authors' own caveat that the supplements used in the trials were not independently analyzed for content (fillers or contaminants possible).

Cognition

Meta-analyses of animal studies show clear memory improvement. Human RCTs are small and inconsistent — not enough to support "curcumin prevents dementia".

The weak point: absorption

Curcumin is notorious for very poor oral absorption. Co-administration with piperine (from black pepper) is reported to raise absorption about 20-fold, and many commercial products use this combination. But "more absorbed = proportionally more benefit" has not been proven.

Safety

No serious adverse events reported at trial doses (50–3,000 mg/day). With biliary disease or anticoagulant use, interactions are possible — consult a physician. High doses cause gastrointestinal symptoms.

Reference product links (in preparation): links to enhanced-absorption and registered products are planned.

Bottom line

Curcumin is "an ingredient that produces numbers for glucose, inflammation and joint pain" — but weaker than drugs, and formulation matters a lot. Evidence for hangover prevention is weak: the Japanese image of "turmeric = hangover cure" does not match what the international meta-analyses actually found. That mismatch is this page's most practical finding.

References

Curcumin on Human Health: A Comprehensive Systematic Review and Meta-Analysis of 103 Randomized Controlled Trials. Adv Nutr (2024). PMID 39478418
The efficacy of curcumin in relieving osteoarthritis: A meta-analysis of meta-analyses. Phytother Res (2024). PMID 38576215
Curcumin effects on glycaemic indices … NAFLD patients: systematic review and meta-analysis. Clin Nutr (2024). PMID 38232906
Targeting cognitive aging with curcumin supplementation: A systematic review and meta-analysis. (2025). PMC12413726

This article is informational, not medical advice. If you have a medical condition or take medication, consult a physician.